Search research articles
Contact Us
Filters
Showing results (31-40 of 164) with videos related to
Page
of 17
Sort By:
Current Urology Reports
|
December 22, 2004
Surveillance following radical or partial nephrectomy for renal cell carcinoma
John S Lam, John T Leppert, Robert A Figlin, et al.
Urology Practice
|
June 20, 2024
Complications: The Experience of the Urologic Surgeon
Doreen E Chung, Dharam Kaushik, Kathleen Kobashi, et al.
Urology
|
October 1, 2005
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma
John S Lam, John T Leppert, Robert A Figlin, et al.
Journal of Endourology
|
January 5, 2017
Defining the Rate of Negative Ureteroscopy in the General Population Treated for Upper Tract Urinary Stone Disease
Remy W Lamberts, Simon L Conti, John T Leppert, et al.
BJU International
|
April 20, 2007
The role of molecular markers in the staging of renal cell carcinoma
John T Leppert, Allan J Pantuck, Robert A Figlin, et al.
World Journal of Urology
|
April 7, 2005
Novel approaches in the therapy of metastatic renal cell carcinoma
John S Lam, John T Leppert, Arie S Belldegrun, et al.
BJU International
|
November 17, 2005
Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery
Dhiren S Dave, John S Lam, John T Leppert, et al.
European Urology
|
March 26, 2013
Diabetic severity and risk of kidney stone disease
Aviva E Weinberg, Chirag J Patel, Glenn M Chertow, et al.
BJU International
|
August 18, 2005
Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options
John S Lam, John T Leppert, Arie S Belldegrun, et al.
Urologic Oncology
|
May 30, 2025
Reality check: The management of small renal masses in 2025 and beyond: Learning from the evolution of prostate cancer care
Simon John Christoph Soerensen, Eugene Shkolyar, Benjamin I Chung, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 164) with videos related to
Sort By:
Page
of 17
Current Urology Reports
|
December 22, 2004
Surveillance following radical or partial nephrectomy for renal cell carcinoma
John S Lam, John T Leppert, Robert A Figlin, et al.
Urology Practice
|
June 20, 2024
Complications: The Experience of the Urologic Surgeon
Doreen E Chung, Dharam Kaushik, Kathleen Kobashi, et al.
Urology
|
October 1, 2005
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma
John S Lam, John T Leppert, Robert A Figlin, et al.
Journal of Endourology
|
January 5, 2017
Defining the Rate of Negative Ureteroscopy in the General Population Treated for Upper Tract Urinary Stone Disease
Remy W Lamberts, Simon L Conti, John T Leppert, et al.
BJU International
|
April 20, 2007
The role of molecular markers in the staging of renal cell carcinoma
John T Leppert, Allan J Pantuck, Robert A Figlin, et al.
World Journal of Urology
|
April 7, 2005
Novel approaches in the therapy of metastatic renal cell carcinoma
John S Lam, John T Leppert, Arie S Belldegrun, et al.
BJU International
|
November 17, 2005
Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery
Dhiren S Dave, John S Lam, John T Leppert, et al.
European Urology
|
March 26, 2013
Diabetic severity and risk of kidney stone disease
Aviva E Weinberg, Chirag J Patel, Glenn M Chertow, et al.
BJU International
|
August 18, 2005
Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options
John S Lam, John T Leppert, Arie S Belldegrun, et al.
Urologic Oncology
|
May 30, 2025
Reality check: The management of small renal masses in 2025 and beyond: Learning from the evolution of prostate cancer care
Simon John Christoph Soerensen, Eugene Shkolyar, Benjamin I Chung, et al.
Page
of 17